Zuberitamab
Zuberitamab (HS006) is a monoclonal antibody that targets CD20 and can be used in cancer research, including diffuse large B-cell lymphoma[1].
Product Specifications
CAS Number
[2251143-19-6]
Product Name Alternative
HS006
UNSPSC
12352203
Target
CD20
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zuberitamab.html
Purity
98.69
Solubility
10 mM in DMSO
Smiles
[Zuberitamab]
Molecular Weight
(145.48 kDa)
References & Citations
[1]Zhen-Hua Wu, et al. Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint. J Immunother Cancer. 2022 Mar;10 (3) :e004054.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2067555-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to 2', 5'-Oligoadenylate Synthetase 1 (OAS1)
Sign In for Pricing
View Details MBS2067555-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to 2', 5'-Oligoadenylate Synthetase 1 (OAS1)
Sign In for Pricing
View Details